Pharmacists in Avon, Ohio


29 Pharmacists found in Avon
female pharmacist

Ms. Irene Orynchak, R.PH.


Pharmacist
36711 American Way, Avon, OH 44011
440-937-2354     440-937-2355

male pharmacist

Dr. Jacob M Cameron, PHARMD


Pharmacist
1810 Nagel Rd, Pharmacy, Avon, OH 44011
440-695-2450     440-695-2465

male pharmacist

Dr. James L Lindon, PHARM.D., PH.D.


Pharmacist
35104 Saddle Crk, Avon, OH 44011
440-333-0011    



female pharmacist

Janet Laurel Winslow, RPH


Pharmacist
35804 Detroit Rd, Avon, OH 44011
440-930-0102    

female pharmacist

Jennifer Molenda, RPH


Pharmacist
36008 Detroit Rd, Avon, OH 44011
440-937-4027     440-937-4038

male pharmacist

Dr. Kenneth Charles Hohmeier, PHARMD



38530 Chester Road, Suite 400, Avon, OH 44011
440-934-3100     440-934-3103

female pharmacist

Dr. Lauren Elizabeth Kessler


Pharmacist
35830 Detroit Rd, T-1325, Avon, OH 44011
440-937-4301    

male pharmacist

Mr. Michael G Bierly, R.PH.


Pharmacist
35804 Detroit Rd, Avon, OH 44011
440-930-0102     440-930-0123

female pharmacist

Nora Elizabeth Mcmanamon, PHARMD, RPH


Pharmacist
35830 Detroit Rd, Avon, OH 44011
440-937-4308    

male pharmacist

Paul Joseph Griesacker, PHARM D


Pharmacist
33564 Augusta Way, Avon, OH 44011
412-478-0170    

female pharmacist

Rebecca Arcaro, PHARMD


Pharmacist
38530 Chester Rd, Suite 400, Avon, OH 44011
440-934-3100     440-934-3103

female pharmacist

Dr. Scarlett M Hohmeier, PHARMD


Pharmacist
38530 Chester Rd, Suite 400, Avon, OH 44011
440-934-3100    

male pharmacist

William Robert Leaser, RPH


Pharmacist
35901 Chester Rd, Avon, OH 44011
440-937-4760    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.